TACROGRAF 1 MG

About

Tacrolimus is a potent calcineurin inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in patients receiving allogeneic liver, kidney, or heart transplants. It works by inhibiting the calcium-dependent phosphatase calcineurin, which is crucial for T-lymphocyte activation and proliferation. By blocking calcineurin, tacrolimus prevents the transcription of various cytokine genes, including interleukin-2, thereby suppressing the immune response that leads to graft rejection.

Its narrow therapeutic index necessitates careful therapeutic drug monitoring to maintain optimal blood levels, balancing efficacy with the minimization of dose-dependent toxicities. This precise management helps prevent both rejection and severe adverse effects, making it a critical medication in the long-term success of organ transplantation.

Uses

• Prophylaxis of organ rejection in liver transplant.
• Prophylaxis of organ rejection in kidney transplant.
• Prophylaxis of organ rejection in heart transplant.
• Treatment of acute rejection episodes (off-label in some cases).

Directions For Use

Take orally twice daily, preferably on an empty stomach, at the same time each day. Dosage is highly individualized and adjusted based on blood levels.

Benefits

• Potent immunosuppressive activity.
• Effective in preventing organ rejection.
• Improves graft survival rates.
• Can be used in combination with other agents.
• Available in various formulations (oral, IV).
• Well-established in transplant medicine.

Side Effects

• Nephrotoxicity (kidney damage)
• Neurotoxicity (tremor, headache, insomnia)
• Hyperglycemia (new-onset diabetes)
• Hypertension
• Diarrhea
• Nausea
• Infections (increased risk)
• Malignancies (increased risk, e.g., PTLD)
• Hyperkalemia
• Hypomagnesemia
• Hepatotoxicity
• Alopecia

Safety Measures

• Alcohol - Alcohol should be avoided as it can increase the risk of liver toxicity and exacerbate gastrointestinal side effects.
• Pregnancy - Tacrolimus crosses the placenta. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.
• Breastfeeding - Tacrolimus is excreted in breast milk. Breastfeeding is not recommended due to potential serious adverse effects in the infant.
• Liver - Use with caution in patients with liver impairment. Dosage adjustments may be necessary, and close monitoring of liver function is crucial.
• Kidney - Nephrotoxicity is a common side effect. Close monitoring of renal function and tacrolimus blood levels is essential.
• Lung - Rare cases of interstitial lung disease have been reported. Monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.